Scientists Create Universal Cells to Fight Cancer: What This Will Change.

Researchers from the Massachusetts Institute of Technology and Harvard Medical School have developed CAR-NK cells that can effectively destroy cancer cells without being rejected by the body. This technology may in the future become the basis for universal immunotherapy against cancer. Scientists added chimeric antigen receptors (CAR) to natural killer cells (NK cells) to enhance their ability to attack cancer tumors.

Effectiveness of New Cells

Researchers have proven that modified CAR-NK cells retain their activity for three weeks, while ordinary cells are quickly rejected. In addition, the new cells help avoid the dangerous inflammatory effect that often occurs during cancer immunotherapy. The next step will be clinical trials on humans to confirm the effectiveness of this technology and explore the possibility of its mass use.

Prospects for Medical Practice

Experts from the Massachusetts Institute of Technology and Harvard Medical School have developed new CAR-NK cells, which could be a significant step in the fight against cancer. These modified immune system cells potentially provide a more effective and safer method for treating this serious disease. The research has shown promising results, and the next steps will be clinical trials that will help determine the possibility of wide implementation of this technology in medical practice.

This breakthrough in medicine opens new horizons for cancer treatment, which requires innovative approaches. If clinical trials confirm the stated effectiveness, CAR-NK cells could significantly change approaches to cancer treatment, providing patients with new hopes for recovery and improving quality of life.